Harvard Bioscience (HBIO) Long-Term Deferred Tax (2010 - 2019)

Harvard Bioscience (HBIO) has 10 years of Long-Term Deferred Tax data on file, last reported at $210000.0 in Q2 2019.

• Long-Term Deferred Tax for Q2 2019 came in at $210000.0, up 18.64% year-over-year; the trailing twelve-month figure through Jun 2019 was $210000.0 (up 18.64% YoY), and the FY2017 annual result was $182000.0, down 84.27% from the prior year.
• Long-Term Deferred Tax advanced to $210000.0 in Q2 2019 per HBIO's latest filing, from $208000.0 in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $11.0 million in Q3 2015 and troughed at -$5.0 million in Q4 2015.
• A 5-year average of $2.2 million and a median of $1.0 million in 2016 frame the typical range for Long-Term Deferred Tax.
• The sharpest annual moves came in 2015 and 2016: Long-Term Deferred Tax slumped 145.08% in 2015, then surged 123.21% in 2016.
• A 5-year view of Long-Term Deferred Tax shows it stood at -$5.0 million in 2015, then surged by 123.21% to $1.2 million in 2016, then plunged by 84.27% to $182000.0 in 2017, then declined by 1.65% to $179000.0 in 2018, then climbed by 17.32% to $210000.0 in 2019.
• Business Quant data shows HBIO's Long-Term Deferred Tax at $210000.0 in Q2 2019, $208000.0 in Q1 2019, and $179000.0 in Q3 2018.